Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS study

OBJECTIVE: To evaluate the effectiveness, treatment patterns and long-term safety of ranibizumab 0.5 mg in treatment-naïve patients with central retinal vein occlusion (CRVO) in a real-world setting. METHODS: LUMINOUS, a 5-year, global, prospective, multicentre, multi-indication, observational, open...

Descripción completa

Detalles Bibliográficos
Autores principales: Lotery, Andrew, Clemens, Andreas, Tuli, Raman, Xu, Xun, Shimura, Masahiko, Nardi, Marco, Ziemssen, Focke, Dunger-Baldauf, Cornelia, Tadayoni, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307792/
https://www.ncbi.nlm.nih.gov/pubmed/34326500
http://dx.doi.org/10.1038/s41433-021-01702-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307792/
https://www.ncbi.nlm.nih.gov/pubmed/34326500
http://dx.doi.org/10.1038/s41433-021-01702-y

Ejemplares similares